The approved drugs for pulmonary arterial hypertension (PAH) treatment primarily include nifedipine, sildenafil, bosentan, beraprost, and imatinib, among others (Zolty, 2020)
Nose Nasal stuffiness, sinusitis, postnasal drip, hoarseness, laryngitis, nose bleeds (epistaxis), and intranasal sores
Full AI Image Prompt: Create a clean regulatory infographic titled GHK-Cu Regulatory Context Map. Show a horizontal map with four labeled blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Include a small callout that says Product category affects evidence and safety interpretation. Use document-style icons, simple arrows, and a professional clinical design with white background, gray, blue, and copper accents
NAPQI detoxification requires glutathione (GSH)